Purchases and Sales Made in Q1 2024 in Enlivex Therapeutics Ltd. (ENLV)
This table provides information about the institutional ownership of Enlivex Therapeutics Ltd. (ENLV) during Q1 2024. The information is specifically focused on institutions that hold shares of Enlivex Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
48.4K+ 683.59% |
$123K - $208K
|
55.5K
$69.4K
|
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
40K+ 143.31% |
$102K - $172K
|
67.9K
$84.9K
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
27.7K+ 62.21% |
$70.3K - $119K
|
72.1K
$90.2K
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
27.7K+ 62.21% |
$70.3K - $119K
|
72.1K
$90.2K
|
|
|
Apr 25, 2024
Q1 2024
|
Simplex Trading, LLC
|
BUY
|
- |
18.3KNew |
$46.4K - $78.5K
|
18.3K
$22.8K
|
|
|
May 13, 2024
Q1 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
7.8K+ 12.56% |
$19.8K - $33.5K
|
69.9K
$87.4K
|
|
|
May 10, 2024
Q1 2024
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
7.22KNew |
$18.3K - $31.1K
|
7.22K
$9.03K
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
6.91K+ 2917.3% |
$17.6K - $29.7K
|
7.15K
$8.94K
|
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 13, 2024
Q1 2024
|
Ubs Group Ag
|
SELL
|
- |
-594- 16.22% |
$1.51K - $2.55K
|
3.07K
$3.84K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-173K- 70.55% |
$439K - $743K
|
72.1K
$90.2K
|